Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Cellular analysis using label-free parallel array microscopy with Fourier ptychography.
Journal: Biomedical optics express
Published: December 14, 2021
Eyes on Lipinski's Rule of Five: A New "Rule of Thumb" for Physicochemical Design Space of Ophthalmic Drugs.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: December 14, 2021
Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker-driven precision dosing.
Journal: Clinical and translational science
Published: November 06, 2020
Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting.
Journal: Clinical pharmacology and therapeutics
Published: November 03, 2020
Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain.
Journal: Clinical pharmacokinetics
Published: August 29, 2020
Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine Programme.
Journal: Journal of Crohn's & colitis
Published: March 13, 2020
Solubilization of Cyclosporine in Topical Ophthalmic Formulations: Preformulation Risk Assessment on a New Solid Form.
Journal: Journal of pharmaceutical sciences
Published: January 15, 2019
Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development.
Journal: Drug discovery today
Published: December 22, 2018
A New Hydrate of Cyclosporine: Structural and Physicochemical Characterization.
Journal: Journal of pharmaceutical sciences
Published: June 05, 2018
A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and future directions.
Journal: Anti-cancer drugs
Published: May 26, 2017
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment.
Journal: Cancer chemotherapy and pharmacology
Published: November 30, 2016
Population Pharmacokinetics and Exposure-Response Relationship of Carfilzomib in Patients With Multiple Myeloma.
Journal: Journal of clinical pharmacology
Published: July 21, 2016
Last Updated: 09/26/2026